Table 1.
Participant demographics and intervention variables by randomized group.
| Factor | FE + RTP (N=16) | VE + RTP (N=16) | RTP + Education (N=8) | p-value |
|---|---|---|---|---|
| Age | 51±12 | 60±14 | 58±12 | 0.14 |
| Male sex (versus female) | 12 (75%) | 10 (62%) | 7 (88%) | 0.43 |
| Race: | 0.11 | |||
| African American | 8 (50%) | 3 (19%) | 4 (50%) | |
| Asian | 1 (6%) | 1 (6%) | 0 (0%) | |
| Other | 2 (12%) | 0 (0%) | 1 (12%) | |
| White | 5 (31%) | 12 (75%) | 3 (38%) | |
| Hispanic ethnicity | 1 (6%) | 0 (0%) | 1 (12%) | 0.67 |
| Dominant side affected (versus non-dominant) | 10 (62%) | 7 (44%) | 5 (62%) | 0.65 |
| Months since stroke | 12 [7,16] | 16 [11,32] | 17 [12,35] | 0.23 |
| Baseline Fugl Meyer score | 37±8 | 33±11 | 33±9 | 0.40 |
| Average cadence (RPM) | 74 [68,82] | 59 [52,66] | -- | 0.008 |
| Aerobic Exercise Intensity (% of HRR) | 60 [48, 65] | 59 [46, 62] | -- | 0.50 |
| Beta Blocker usage, N (percentage) | 8 (50%) | 6 (37%) | 5 (62%) | 0.50 |
| Aerobic exercise time (min/session) | 43.0 [39.7, 44.2] | 43.3 [42.1, 44.6] | 0.36 | |
| Power (watts) | 32.4 [24.1, 41.8] | 33.9 [28.3, 54.9] | -- | 0.72 |
| Average number of repetitions/session | 276 [248,322] | 264 [232,328] | 306 [268,440] | 0.50 |
Summary statistics presented as mean ± standard deviation for normally distributed data, median [Q1, Q3] for skew data, or N (%) for categorical data.